A Growing Clinical Stage Product Pipeline
We are developing a portfolio of novel, oral product candidates aimed at large, chronic markets. We currently have four product candidates in clinical trials, three of which are in Phase 2 development.
Learn more
RetroMetabolic Drug Design™
We use proprietary technologies to design structurally unique and patentable molecules that retain the efficacy of proven therapies while eliminating specific adverse side effects associated with these therapies.
Learn more
Careers at ARYx
If you are a highly motivated professional who welcomes creative challenges, we invite you to investigate career opportunities at ARYx.
Learn more
ARYx Therapeutics at Morgan Stanley 2008 Global Healthcare Unplugged Conference